<DOC>
	<DOCNO>NCT00356603</DOCNO>
	<brief_summary>This study conduct collect case treat self-injection sumatriptan 3mg kit product treatment migraine cluster headache attack clinical setting , demonstrate efficacy , examine patient acceptability ( simplicity usefulness ) rate successful self-injection .</brief_summary>
	<brief_title>Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine Cluster Headache In Japan</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Cluster Headache</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<criteria>Inclusion criterion : Diagnosis migraine ( without aura ) cluster headache accord International Classification Headache Disorders , Version 2 ( ICHDII ) History migraine cluster headache persist least 6 month Migraine : One 6 attack moderate severer headache per month 2 month prior enrollment Cluster Headache : Each attack persist least 45 minute Written inform consent obtain patient . When patient minor , write informed consent his/her proxy consenter ( e.g. , person parental authority ) also require . Exclusion criterion : History hypersensitivity ingredient 5HT1B/1D receptor antagonist ( e.g. , triptans ) serious AE due treatment drug History serious adverse event attributable treatment ImigranÂ® Injection 3 History myocardial infarction , current previous history ischemic heart disease symptoms/signs , current history atypical variant angina ( coronary arteriospasm ) Previous history cerebrovascular disorder transient cerebral ischemic attack Current previous history peripheral angiopathy ( include Raynaud 's syndrome ) Systolic blood pressure ( SBP ) &gt; 160 mmHg diastolic blood pressure ( DBP ) &gt; 95 mmHg start treatment period Current familial hemiplegic migraine , basilar migraine , sporadic hemiplegic migraine Current abuse ergotamine dihydroergotaminecontaining preparation triptans Pregnant woman , lactate mother , woman may pregnant , woman childbearing potential use appropriate contraceptive measure . Epilepsy organic cerebral disorder may lead convulsion Previous history hypersensitivity sulfonamides Known drug allergy idiosyncrasy Known drug dependency alcoholism</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Sumatriptan Succinate Injection Kit</keyword>
	<keyword>Cluster Headache</keyword>
	<keyword>self-injection</keyword>
</DOC>